Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer

Programmed death-1 (PD-1) and its ligand are part of the immune checkpoint pathway that down-regulates effector T cells in immune response, thereby causing immune suppression. The PD-1/programmed death-ligand 1 (PD-L1) pathway can be blocked by antibodies to reverse tumor-mediated immunosuppression....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xinxin, Lang, Jinghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540723/
https://www.ncbi.nlm.nih.gov/pubmed/28657225
http://dx.doi.org/10.3802/jgo.2017.28.e64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540723/
https://www.ncbi.nlm.nih.gov/pubmed/28657225
http://dx.doi.org/10.3802/jgo.2017.28.e64

Ejemplares similares